Therapy of Inflammatory Bowel Disease: New Medical and Surgical Approaches

5-aminosalicylic acid 5-ASA enemas abdominal absorption abstr ACTH agents anal anastomosis antibiotics azathioprine Brooke ileostomy cholestyramine chronic ulcerative colitis Clin colectomy colon complications continent ileostomy continued controlled trial corticosteroid therapy corticosteroids cortisone Crohn's disease decrease diarrhea diet disease activity dosage dose double-blind drug efficacy enemas fistulas g/day Gastroenterol Gastroenterology hydrocortisone IBD patients ileal pouch-anal anastomosis ileitis ileorectal anastomosis ileostomy ileum illness immunosuppressive improvement increased inflammatory bowel disease intestinal intravenous Korelitz Lancet levels long-term mesalazine metabolism metronidazole months mucosa occur olsalazine oral parenteral nutrition patients with active patients with Crohn's patients with IBD patients with ulcerative perineal pharmacokinetics placebo plasma pouch prednisolone prednisone pregnancy prostaglandin protein rectal rectum recurrent relapse remission reported resection response Scand serum side effects small bowel steroids stoma stool sulfapyridine sulfasalazine Surg surgery surgical symptoms therapeutic tion tixocortol toxic treated treatment of Crohn's treatment of ulcerative ulcerative colitis weeks